BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33347888)

  • 1. Active and Inactive Cdc42 Differ in Their Insert Region Conformational Dynamics.
    Haspel N; Jang H; Nussinov R
    Biophys J; 2021 Jan; 120(2):306-318. PubMed ID: 33347888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations reveal the activation mechanism of mutations G12V and Q61L of Cdc42.
    Chen S; Shu L; Zhao R; Zhao Y
    Proteins; 2022 Jul; 90(7):1376-1389. PubMed ID: 35152498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42.
    Phillips MJ; Calero G; Chan B; Ramachandran S; Cerione RA
    J Biol Chem; 2008 May; 283(20):14153-64. PubMed ID: 18348980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic GTP hydrolysis is observed for a switch 1 variant of Cdc42 in the presence of a specific GTPase inhibitor.
    Morris KM; Henderson R; Suresh Kumar TK; Heyes CD; Adams PD
    Small GTPases; 2016; 7(1):1-11. PubMed ID: 26828437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanine nucleotide induced conformational change of Cdc42 revealed by hydrogen/deuterium exchange mass spectrometry.
    Yang SW; Ting HC; Lo YT; Wu TY; Huang HW; Yang CJ; Chan JF; Chuang MC; Hsu YH
    Biochim Biophys Acta; 2016 Jan; 1864(1):42-51. PubMed ID: 26542736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC42-IQGAP Interactions Scrutinized: New Insights into the Binding Properties of the GAP-Related Domain.
    Mosaddeghzadeh N; Pudewell S; Bazgir F; Kazemein Jasemi NS; Krumbach OHF; Gremer L; Willbold D; Dvorsky R; Ahmadian MR
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A switch I mutant of Cdc42 exhibits less conformational freedom.
    Chandrashekar R; Salem O; Krizova H; McFeeters R; Adams PD
    Biochemistry; 2011 Jul; 50(28):6196-207. PubMed ID: 21667996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
    Lu S; Jang H; Nussinov R; Zhang J
    Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of CDC42 GDP-bound state by Rho-GDI inhibits MAP kinase activation by the exchange factor Ras-GRF. evidence for Ras-GRF function being inhibited by Cdc42-GDP but unaffected by CDC42-GTP.
    Arozarena I; Matallanas D; Crespo P
    J Biol Chem; 2001 Jun; 276(24):21878-84. PubMed ID: 11285260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
    Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
    J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural coupling between the Rho-insert domain of Cdc42 and the geranylgeranyl binding site of RhoGDI.
    Abramovitz A; Gutman M; Nachliel E
    Biochemistry; 2012 Jan; 51(2):715-23. PubMed ID: 22206343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
    Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
    J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of an inactive conformation of GTP-bound RhoA GTPase.
    Lin Y; Lu S; Zhang J; Zheng Y
    Structure; 2021 Jun; 29(6):553-563.e5. PubMed ID: 33497604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic Cdc42 mutants are potent activators of cellular transformation.
    Tu SS; Wu WJ; Yang W; Nolbant P; Hahn K; Cerione RA
    Biochemistry; 2002 Oct; 41(41):12350-8. PubMed ID: 12369824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the nucleotide exchange factor ITSN1L: evidence for a kinetic discrimination of GEF-stimulated nucleotide release from Cdc42.
    Kintscher C; Groemping Y
    J Mol Biol; 2009 Mar; 387(2):270-83. PubMed ID: 19356586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the catalytic mechanism of GTPase-activating proteins: demonstration of the importance of switch domain stabilization in the stimulation of GTP hydrolysis.
    Fidyk NJ; Cerione RA
    Biochemistry; 2002 Dec; 41(52):15644-53. PubMed ID: 12501193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide binding switches the information flow in ras GTPases.
    Raimondi F; Portella G; Orozco M; Fanelli F
    PLoS Comput Biol; 2011 Mar; 7(3):e1001098. PubMed ID: 21390270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unraveling the molecular mechanism of interactions of the Rho GTPases Cdc42 and Rac1 with the scaffolding protein IQGAP2.
    Ozdemir ES; Jang H; Gursoy A; Keskin O; Li Z; Sacks DB; Nussinov R
    J Biol Chem; 2018 Mar; 293(10):3685-3699. PubMed ID: 29358323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes.
    Johnson JL; Erickson JW; Cerione RA
    J Biol Chem; 2009 Aug; 284(35):23860-71. PubMed ID: 19581296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational transformation of switch domains in GDP/K-Ras induced by G13 mutants: An investigation through Gaussian accelerated molecular dynamics simulations and principal component analysis.
    Chen J; Wang L; Wang W; Sun H; Pang L; Bao H
    Comput Biol Med; 2021 Aug; 135():104639. PubMed ID: 34247129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.